Heart Disease Clinical Trials in Chicago

Showing 161-180 of 505 trials

Early Intervention to Promote Cardiovascular Health of Mothers and Children

NCT05856162

The goal of this clinical trial is to examine whether a multi-component intervention delivered during pregnancy and after delivery can improve the cardiovascular health of pregnant individuals enrolled in home visiting programs, as well as their offspring's cardiovascular health. The main questions it aims to answer are: 1. Does a multi-component intervention improve cardiovascular health of pregnant individuals and new mothers enrolled in home visiting programs? 2. Does a multi-component intervention improve cardiovascular health of the offspring of pregnant individuals/new mothers enrolled in home visiting programs? Participants receiving the multi-component intervention will receive content on promoting cardiovascular health delivered by their home visitor and asynchronously. All participants will be asked to complete assessments at baseline, 2-month follow-up, and 4-month follow-up. The investigators will compare whether pregnant individuals and new mothers randomized to the intervention group, and their offspring, exhibit better cardiovascular health than pregnant individuals and new mothers randomized to the control group.

Cardiovascular Diseases

Northwestern University18 participantsStarted Aug 2023

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603

Phase 2 study to evaluate the efficacy and safety of intermittent levosimendan compared with placebo in hemodynamic improvement with exercise in PH-HFpEF subjects

Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction

Tenax Therapeutics, Inc.44 participantsStarted Nov 2018

Stanford, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

Early Intervention to Promote Cardiovascular Health of Mothers and Children

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Heart Disease Trials in Other Cities

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

REmodeling the Left Ventricle With Atrial Modulated Pacing

Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Physiologic Pacing Registry

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Benefits of Microcor in Ambulatory Decompensated Heart Failure

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Acorai Machine Learning Generalization (MLG) Study

Other Conditions in Chicago